IL1B and COVID-19: In support of this second conclusion, we failed to observe any significant IL-1β mediated inflammation in the COVID -SSNHL group suggesting either non-IL-1β -mediated inflammation or, more likely, the patients experienced a SSNHL that is unrelated to COVID-19.